Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

3.09
Delayed Data
As of Jul 22
 +0.01 / +0.32%
Today’s Change
2.28
Today|||52-Week Range
11.65
-33.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues289.0K733.0K1.9M145.0K
 
 
 
 
 
Depreciation And Amortization72.0K73.0K72.0K72.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses10.2M12.4M10.4M11.8M
 
 
 
 
 
Research And Development8.5M10.4M8.6M9.6M
 
 
 
 
 
Total Operating Expenses10.2M12.5M10.5M11.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.9M-11.7M-8.6M-11.7M
 
 
 
 
 
Other Expenses1.1M391.0K1.2M-9.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.9M-11.3M-7.3M-11.7M
 
 
 
 
 
Net Income-8.9M-11.3M-7.3M-11.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS35.8M39.2M39.9M40.0M
 
 
 
 
 
Shares To Calculate EPS Diluted35.8M39.2M39.9M40.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.29-$0.18-$0.29
 
 
 
 
 
EPS Diluted-$0.25-$0.29-$0.18-$0.29